IL201318A0 - Use of hdac inhibitors for the treatment of gastrointestinal cancers - Google Patents

Use of hdac inhibitors for the treatment of gastrointestinal cancers

Info

Publication number
IL201318A0
IL201318A0 IL201318A IL20131809A IL201318A0 IL 201318 A0 IL201318 A0 IL 201318A0 IL 201318 A IL201318 A IL 201318A IL 20131809 A IL20131809 A IL 20131809A IL 201318 A0 IL201318 A0 IL 201318A0
Authority
IL
Israel
Prior art keywords
treatment
hdac inhibitors
gastrointestinal cancers
cancers
gastrointestinal
Prior art date
Application number
IL201318A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39683987&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL201318(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL201318A0 publication Critical patent/IL201318A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Indole Compounds (AREA)
IL201318A 2007-05-04 2009-10-01 Use of hdac inhibitors for the treatment of gastrointestinal cancers IL201318A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91599607P 2007-05-04 2007-05-04
PCT/US2008/062341 WO2008137630A1 (en) 2007-05-04 2008-05-02 Use of hdac inhibitors for the treatment of gastrointestinal cancers

Publications (1)

Publication Number Publication Date
IL201318A0 true IL201318A0 (en) 2010-05-31

Family

ID=39683987

Family Applications (1)

Application Number Title Priority Date Filing Date
IL201318A IL201318A0 (en) 2007-05-04 2009-10-01 Use of hdac inhibitors for the treatment of gastrointestinal cancers

Country Status (16)

Country Link
EP (1) EP2142190A1 (ar)
JP (1) JP2010526149A (ar)
KR (1) KR20100016171A (ar)
CN (1) CN101674825A (ar)
AU (1) AU2008247603A1 (ar)
BR (1) BRPI0811112A2 (ar)
CA (1) CA2683554A1 (ar)
CL (1) CL2008001269A1 (ar)
IL (1) IL201318A0 (ar)
MA (1) MA31356B1 (ar)
MX (1) MX2009011692A (ar)
RU (1) RU2009144842A (ar)
TN (1) TN2009000427A1 (ar)
TW (1) TW200908964A (ar)
WO (1) WO2008137630A1 (ar)
ZA (1) ZA200906739B (ar)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117603123A (zh) * 2023-11-04 2024-02-27 郑州大学 新型吲哚类hdac6小分子抑制剂、制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020354A1 (es) * 2000-09-01 2002-06-12 Novartis Ag Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
JP2007509930A (ja) * 2003-10-27 2007-04-19 エス＊バイオ プライベート リミティッド アシル尿素およびスルホニル尿素が結合したヒドロキサマート
EP1682538A4 (en) * 2003-10-27 2009-05-27 S Bio Pte Ltd BIARYL-ASSOCIATED HYDROXAMATE: PREPARATION AND PHARMACEUTICAL APPLICATIONS
WO2006075165A1 (en) * 2005-01-13 2006-07-20 Btg International Limited Combination of oncolytic viruses with angiogenesis inhibitors

Also Published As

Publication number Publication date
AU2008247603A1 (en) 2008-11-13
BRPI0811112A2 (pt) 2014-12-23
JP2010526149A (ja) 2010-07-29
EP2142190A1 (en) 2010-01-13
CL2008001269A1 (es) 2008-12-19
CA2683554A1 (en) 2008-11-13
MA31356B1 (ar) 2010-05-03
CN101674825A (zh) 2010-03-17
RU2009144842A (ru) 2011-06-10
WO2008137630A1 (en) 2008-11-13
ZA200906739B (en) 2010-06-30
MX2009011692A (es) 2009-11-10
TN2009000427A1 (en) 2011-03-31
KR20100016171A (ko) 2010-02-12
TW200908964A (en) 2009-03-01

Similar Documents

Publication Publication Date Title
IL248204A0 (en) Combined treatment of tumors expressing 38cd
HUE038452T2 (hu) Gyomor és bélrendszeri gyulladások kezelésére szolgáló kompozíciók
PL2391650T3 (pl) Sposoby leczenia dny
EP2200439A4 (en) HDAC INHIBITORS
PL2303021T3 (pl) Związki do leczenia nowotworu
PL2040753T3 (pl) Inhibitory progastryny w leczeniu raka okrężnicy
EP2049139A4 (en) TREATMENT OF TUMORS EXPRESSING RAS
ZA201003425B (en) 5-cyano-thienopyridines for the treatment of tumors
ZA201000427B (en) Treatment of melanoma
EP2352501A4 (en) COMPOUNDS FOR THE TREATMENT OF OSTEOPOROSIS AND CANCERS
IL210066A0 (en) Novel ortho-aminoanilides for the treatment of cancer
PL2263751T3 (pl) Związki izoksazolowe do leczenia raków przewodu pokarmowego
GB0723100D0 (en) Treatment of HFnEF
IL201466A0 (en) Use of hdac inhibitors for the treatment of bone destruction
IL201318A0 (en) Use of hdac inhibitors for the treatment of gastrointestinal cancers
HK1140142A (en) Use of hdac inhibitors for the treatment of gastrointestinal cancers
ZA200906906B (en) Use of HDAC inhibitors for the treatment of melanoma
IL201439A0 (en) Use of hdac inhibitors for the treatment of melanoma
GB0602857D0 (en) The treatment of sialorrhoea
HK1137934A (en) Use of hdac inhibitors for the treatment of melanoma
PL2214677T3 (pl) Kompozycje do leczenia zapalenia przewodu pokarmowego
GB0604114D0 (en) Combinations for the treatment of cancer
GB0712513D0 (en) Treatment of cancer
GB0602855D0 (en) The Treatment Of Sialorrhoea
GB0602858D0 (en) The treatment of sialorrhoea